AIM Biotech
  • HOME
    • ABOUT US
    • CAREERS
    • NEWSROOM
  • TECHNOLOGY
    • TECHNOLOGY
    • APPLICATIONS
    • PUBLICATIONS
  • PRODUCTS
    • CHIPS
    • ACCESSORIES
    • RESEARCH SERVICES
  • PROTOCOLS
    • GENERAL PROTOCOLS
    • APPLICATION-SPECIFIC PROTOCOLS
    • VIDEOS
    • PROTOCOL SUBMISSION
  • SUPPORT
    • CONTACT US
    • FAQ
    • TIPS & TRICKS
    • BROCHURES
    • APPLICATION NOTES
    • FORUMS
  • STORE
    • DISTRIBUTORS

Nature Medicine paper on "Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses" employs AIM chips for in vitro immune checkpoint assays

30/7/2018

1 Comment

 
Picture
A Nature Medicine paper by researchers from the Dana-Farber Cancer Institute, NYU and others  features the discovery of a new genetic profile, SPARCS that predicts tumor immune response. The authors used AIM chips and human NSCLC biopsies to show that SPARCS_high profiles correspond with positive immune-checkpoint responses. 

1 Comment

    Archives

    January 2020
    December 2019
    November 2018
    October 2018
    August 2018
    July 2018
    April 2018
    November 2017
    July 2017
    April 2017
    December 2016
    July 2016
    March 2016
    January 2016
    December 2015
    September 2015
    August 2015

    Categories

    All

    RSS Feed

Picture
About AIM Biotech
Contact Us
Newsroom
Subscribe to AIM Biotech's mailing list

This website and its content is copyright of AIM Biotech Pte. Ltd.
​© AIM Biotech Pte. Ltd. 2020. All rights reserved.